High Dose Statin treatment with Acute Coronary Syndrome study

A Multicentric Academic Study on Utility Pattern of High Dose Statin therapy with Acute Coronary Syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/12/010825

Enrollment

300

Registered

2017-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- The subjects are patients who are presenting with a diagnosis of ACS, at the hospital.

Interventions

Intervention1: Group I: Statin 40 mg / day Group II: Statin 80 mg / day: This is a prospective descriptive study,an academic study to be conducted at tertiary hospitals

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age more than 18 years. 2. Patients with ACS. 3. Willing to sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with Pre Existing Liver Disease. 2. Patients with Proven Statin Intolerant. 3. Patients already on Moderate to High Dose Statin.

Design outcomes

Primary

Measure	Time frame
1. To study the outcomes with high dose statin with regards to primary outcomes including MACE, Composite of Myocardial Infarction, Death and Revascularization.Timepoint: Data will be collected for a period of 1 year and based on stipulated study outcome measures, the efficacy of investigational product High dose statin is to be evaluated in comparison to standard care by using appropriate statistical methods and final report to be prepared.	—

Measure

Time frame

1. To study the outcomes with high dose statin with regards to primary outcomes including MACE, Composite of Myocardial Infarction, Death and Revascularization.Timepoint: Data will be collected for a period of 1 year and based on stipulated study outcome measures, the efficacy of investigational product High dose statin is to be evaluated in comparison to standard care by using appropriate statistical methods and final report to be prepared.

—

Secondary

Measure	Time frame
2. To study the complications of administering high dose statins in the study population.Timepoint: in 12 months	—

Countries

India

Contacts

Public ContactDr S Thanikchalam

Sri Ramachandra University

drthanikachalamsyndrom@gmail.com044-24766991

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026